+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Atrial natriuretic peptide in relative polycythemia and polycythemia vera



Atrial natriuretic peptide in relative polycythemia and polycythemia vera



Haematologica 74(4): 351-353



Atrial natriuretic peptide (ANP) levels have been tested in patients with chronic relative polycythemia (RP), polycythemia vera, and in healthy subjects in order to find a possible underlying pathophysiological mechanism for relative polycythemia. No difference in statistical significance has been found between the mean atrial natriuretic peptide levels of the polycythemic patients and the control group. It is suggested that ANP probably plays no significant role in the contraction of plasma volume observed in normotensive patients with RP.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007042698

Download citation: RISBibTeXText

PMID: 2529200


Related references

Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera. Blood 89(10): 3574-3581, 1997

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials. Haematologica 102(6): E219-E221, 2017

RES scintigraphy in polycythemia vera and secondary or relative polycythemia. Acta Radiologica 34(2): 183-186, 1993

Thromboembolic complications of polycythemia: Polycythemia vera versus smokers' polycythemia. Journal of Vascular Surgery 17(3): 518-522, 1993

Rapidly progressed aortic stenosis in a patient with previous diagnosis of polycythemia vera and post-polycythemia vera myelofibrosis. Clinical Case Reports 4(6): 589-592, 2016

Cerebro vascular complications of polycythemia vera a case report and incidence of polycythemia vera with apoplexy in japan. Clinical Neurology (Tokyo) 10(10): 585-592, 1970

Relation of polycythemia vera (Vaquez' disease) to myelosclerosis and leukosis. Polycythemia vera and so-called myeloproliferative states. La Revue du Praticien 12: 2399-2410, 1962

A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2833-2837, 1994

Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia only polycythemia vera has endogenous colonies. Leukemia Research 13(4): 331-338, 1989

The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood 99(4): 1144-1149, 2002

Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells A possible defect of phosphatase activity in polycythemia vera. Blood 88(10 Suppl. 1 Part 1-2): 145A, 1996

Acute leukemia , hydroxyurea and polycythemia vera An analysis of risk from the Polycythemia Vera Study Group. Blood 84(10 Suppl. 1): 518A, 1994

From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Seminars in Hematology 34(1): 17-23, 1997

Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols. American Journal of Hematology 16(4): 367-374, 1984

Bayesian validation of Polycythemia Vera Study Group criteria for diagnosis of polycythemia rubra vera. Blood 86(10 Suppl. 1): 793A, 1995